“Similia Similibus Curentur”: Ensuring the Dependability of Modern Materia Medica

Pathogenetic trials (provings) are a critical pillar of homeopathic science and form the basis of the application of the similia principle in clinical practice. The last two decades have seen a groundswell of proving enthusiasm, and a plethora of new provings derived by a range of methodologies and often obscure analyses. Many of these have been incorporated into our Materia Medica. In this paper, the author identifies challenges impacting the consistency and reliability of proving outcomes, the traceability of proving data, and global efforts to “firm up” the scientific and regulatory dependability of proving outcomes through the formulation of guidelines. He draws on his experience within this critical area of homeopathic research to emphasise the central importance of pathogenetic trial research within homeopathic science, the incontestable requirement of dependable and traceable Materia Medica in a clinical context, and shares methodological insights around protecting the inherently artistic nature of the proving experiment in an increasingly regulatory environment. Homeopathic practice, as a consistent application of the similia principle, is critically dependent on a Materia Medica that accurately and dependably traces the clear pathogenetic effects of proved substances on healthy human beings. In this regard, the author also shares his perspective on the clear differentiation of experimental effects, analysis, and tracing of proving data, and the risks of incorporation of spurious proving outcomes into our primary Materia Medica and repertorial sources.